PAC-41321-35237
2 vaccinations
3 coded responses
25 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 441 / OH
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
-
2020-12-24
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-25
- 2021-01-03
- 2021-01-09
-
2021-01-15
Dose 2 — Pfizer-BioNTech
- 2021-01-15
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, DiarrheaAdult check-in
- 2021-01-18
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-04-18
-
2021-07-16
Survey response — 6 months, dose 2MedDRA: Abortion spontaneous — Feeling: GoodFree text: MiscarriageMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-01-17
Survey response — 12 months, dose 2MedDRA: Benign hydatidiform mole — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Molar pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-01-17
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-17 | Unsuccessful |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Runny nose
Release 9 — 6 months, dose 2
Symptoms: Miscarriage
Release 10 — 12 months, dose 2
Symptoms: Molar pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | ✓ | · | ✓ |
| SD | Benign hydatidiform mole | · | · | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release